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It has been recently proposed that nanomaterials, alone or in concert with their specific biomolecular conjugates,
can be used to directly modulate the immune system, therefore offering a new tool for the enhancement of
immune-based therapies against infectious disease and cancer. Here, we revised the publications on the impact of
functionalized carbon nanotubes (f-CNTs), graphene and carbon nanohorns on immune cells. Whereas f-CNTs are
the nanomaterial most widely investigated, we noticed a progressive increase of studies focusing on graphene in
the last couple of years. The majority of the works (56%) have been carried out on macrophages, following by
lymphocytes (30% of the studies). In the case of lymphocytes, T cells were the most investigated (22%) followed by
monocytes and dendritic cells (7%), mixed cell populations (peripheral blood mononuclear cells, 6%), and B and
natural killer (NK) cells (1%). Most of the studies focused on toxicity and biocompatibility, while mechanistic insights
on the effect of carbon nanotubes on immune cells are generally lacking. Only very recently high-throughput
gene-expression analyses have shed new lights on unrecognized effects of carbon nanomaterials on the immune
system. These investigations have demonstrated that some f-CNTs can directly elicitate specific inflammatory
pathways. The interaction of graphene with the immune system is still at a very early stage of investigation. This
comprehensive state of the art on biocompatible f-CNTs and graphene on immune cells provides a useful compass
to guide future researches on immunological applications of carbon nanomaterials in medicine.
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DiagnosisIntroduction
In the burgeoning area of nanotechnology, scientists are
nowadays deeply focusing on the translational application
of nanomaterials in medicine. Whereas findings from
physics, genetics and immunology have already changed
the everyday clinical practice in several fields, nano-
technology is expanding its legacy by implementing ap-
proaches aimed at delivering therapeutics [1-3] and
developing new diagnostic imaging tools [4-6]. One of the
most fascinating frontiers of nanotechnology is the devel-
opment of nanomaterials for diagnostic and therapeutic* Correspondence: a.bianco@ibmc-cnrs.unistra.fr; lgdelogu@uniss.it
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article, unless otherwise stated.purposes at the same time. These materials are indicated
as theranostic nanomaterials or nanoparticles [7].
For any translational application of nanotechnology in
medicine, a critical step is represented by the assessment
of their impact on the immune system, independently of
their specific purpose [8]. In fact, following parenteral
administration (e.g. intravenous, intramuscular, subcuta-
neous, etc.), nanomaterials immediately enter in contact
with peripheral immune cells either in the blood or in
the peripheral tissues.
In this review, we primarily focused on the immuno-
logical impact of one of the most studied nanomaterials
for biomedicine applications, namely functionalized car-
bon nanotubes [9,10] (f-CNTs). Non functionalized (pris-
tine) carbon nanotubes are virtually insoluble in water,
tend to form intracellular conglomerates and induce con-
siderable cytotoxicities, therefore limiting their application
as diagnostic or therapeutic materials. Conversely, theirtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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fluids and enhances nanotube biocompatibility. We
considered CNTs as functionalized when they present
on their surface any molecule covalently linked or
adsorbed. Moreover, we took into consideration graphene,
the new promising form of carbon [11]. Graphene is a
single-layer two-dimensional sp [2] carbon nanomaterial
and it has attracted tremendous attention for its intriguing
physical, chemical and mechanical properties [12]. We
summarized recent studies on the interaction of pristine
graphene and graphene oxide (GO), with immune cells.
Carbon nanohorns were also taken into consideration
because they share with the above mentioned materials
similar chemical characteristics. We considered the het-
erogeneity among the different functionalizations and
described the impact on the major peripheral blood
mononuclear cell (PBMC) populations: lymphocytes,
monocytes and their differentiated progenies (dendritic
cells and macrophages). Furthermore, we discerned
lymphocyte subpopulations for each reported studies.
Most relevant findings are discussed in the text. The
diversity of the nanomaterials here investigated and theA
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different immune cell populations. B) Percentage of publications according
represents the exact number of publications per cell type. C) Species exam
human and mouse).large area of immune-related publications make this re-
view a useful compass in the fascinating world of immune
nanotechnology. With a comprehensive state of the art on
functionalized biocompatible carbon nanotubes and gra-
phenes, we aimed at depicting a picture of their interac-
tions with the immune system per se and in concert with
their specific biomolecule conjugations.
Studies selection criteria and overview
To achieve our purpose, we performed a PubMed search
using the following keywords in different combinations:
functionalized carbon nanotubes, graphene, carbon nano-
horns, lymphocytes, T cells, B cells, NK cells, peripheral
blood mononuclear cell, dendritic cells, monocytes, macro-
phages, immune system and immune cells. Keyword ex-
ploration was performed one by one and as well as in
several different combinations. Study lists reported include
all the retrieved publications from 2005 to September
2013. High impact review articles also served as additional
tool. To assess what type of cells were most investigated
for their interaction with f-CNTs and graphene we summa-
rized the publication according to the cell type (Figure 1A).Macrophages
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macrophages probably because of their extremely import-
ant function to attack foreign invader bacteria, viruses and
also foreign nanomaterials. Lymphocytes were the second
biggest portion of the pie with a 30% of studies. However,
we found a huge gap in the different types of lymphocyte
populations. T lymphocytes were the most investigated
(22%) followed by the mix of cell populations (peripheral
blood mononuclear cells, PBMCs), with a 6% of the stud-
ies. B cells and NK cells were less investigated with only a
1% of studies each. Studies related to the innate immune
cells, others than on macrophages and NK cells, focused
on monocytes (7%) and dendritic cells (DCs; 7%). In
Figure 1B we show that among 86 publications, the
majority of them focused on one cell type (70) and only
1 publication looked at four different immune cell types
at the same time. To our knowledge, no investigations
have assessed so far on more than four immune cell
populations in their interaction with f-CNTs. In Figure 1C
we report the number of researches conducted on
humans, mice, or both, comprising to in vitro or ex vivo
for human studies and in vivo in case of experiments
conducted in mouse models. Even though scientists
should have caution in translating their findings from
mouse to human, our investigation clearly shows that
the majority of the studies were conducted on mice
(60%), 32% in humans and very few on both (8%). To
investigate the degree of scientific interest triggered by
different carbon materials, we compared f-CNTs and
graphenes (pristine graphene and GO) in terms of number
of publications (Figure 2A). In the last years, f-CNTs have
been extensively explored for their applications as drug
carriers, targeted materials and scaffolds [9]. These works
have generated a considerable quantity of ancillary data onA
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Figure 2 Status of carbon nanomaterials publications in the last 8 ye
and their interactions with immune cells (2005 to September 2013). B) Perc
categorized by their number of graphite layers: single-walled (SWCNTs), dotheir impact on the immune system. Graphene, which has
a younger history compared to CNTs, is overall less stud-
ied. However, starting from 2012, we noticed an opposite
trend, with an increasing number of studies focusing on
graphene and GO, resulting in a progressive enrichment
of publications dealing with this material in the last couple
of years (Figure 2A). This observation reflects the growing
interest for graphene among the scientific community.
Carbon nanotubes have many structures, differing in
length, thickness, and number of graphite layers. In
Figure 2B we focused on the different forms f-CNTs
categorized by their number of graphite layers: single
walled (SWCNTs), double walled (DWCNTs) and multi-
walled (MWCNTs). MWCNTs are the most investigated
type for their interaction with immune cell (47%), prob-
ably because their cost is lower compare to SWCNTs
which have been explored in the 45% of studies. A highly
useful comparison between the two types of nanotubes
was performed in only a small proportion of studies (6%).
Lymphocytes
Lymphocytes represent about 20-40% of white blood
cells (i.e., 70-90% of PBMCs) and are responsible for the
antigen-specific (B and T cells) and innate (NK cells)
characteristics of immune response. In Additional file 1
we summarized the studies conducted so far evaluating
the impact of f-CNTs, graphenes, and carbon nanohorns
in these cells [13-39]. One of the first work on CNTs,
functionalized by 1,3-dipolar cycloaddition reaction and
by oxidation/amidation treatment, was conducted by
Dumortier et al. in 2006 [16]. The study demonstrated
the non toxicity of well functionalized CNTs on primary
mouse T and B cells. A year later, the group of Dai, while
studying a specific siRNA delivery system against CXCR4B
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revealed the non toxicity of pegylated CNTs on human
T cell lines and primary T cells [17]. Delogu et al. [21]
focusing on the use of CNTs for drug delivery to knock-
down PTPN22, a gene related to type 1 diabetes [40],
confirmed the non toxicity of PEGylated CNTs on T
cells. Similar results were also found by Cato et al. [18].
A systematic genotoxic study [23] reported the effect of
SWCNTs, MWCNTs, and amidated SWCNTs on cul-
tured human lymphocytes. This investigation showed
that, in contrast to non functionalized CNTs, the amida-
tion of SWCNTs did not disturb the T cell proliferation,
therefore preserving T cells from the observed genotoxi-
city. The studies discussed above highlights that different
type of functionalizations such as 1,3-dipolar cycloadd-
ition, adsorption with phospholipids and polyethylene
glycol, and amidation are fundamental for preserving
viability of treated cells. Furthermore, other than ad-
dressing biocompatibility issues, Fadel et al. suggested
that f-CNTs can be potentially used in the context of
immunotherapy [19]. They proved that anti-CD3 adsorbed
onto SWNTs bundles stimulate T cell lines more effect-
ively than equivalent concentrations of soluble anti-CD3.
However, the stimuli was more efficient with functional-
ized versus non functionalized nanotubes [25]. The groups
of Bianco and Gennaro demonstrated that two different
conjugates f-CNTs and amphotericin B can achieve an an-
tifungal activity comparable to, or better than, amphoteri-
cin alone in T cell lines (jurkat cells) [27]. A large number
of studies took advantage of the easiness of culturing cell
lines such as jurkat cells [13-15,18,21,26-28,39], a line
established from the peripheral blood of a 14 year old
child affected by T cell leukemia. The clear advantages in
using this cell model (highly reproducible experiments,
low cost and favorable culture conditions) are somehow
in contrast with its neoplastic characteristics that may
not always reflect the in vivo physiological condition of
T cell behavior. To avoid this concern, in a recent study,
we explored the impact of different functionalized
MWCNTs on PBMCs from healthy donors [31]. Two
types of multi-walled carbon nanotubes (of low, 9.5 nm,
and big, 20–30 nm, diameter) were initially oxidized
and further modified by 1,3-dipolar cycloaddition reac-
tion to obtain ammonium-functionalized nanotubes.
After having excluded in vitro toxicity and confirmed
their dose-depending uptake, we observed that f-CNTs
with smaller diameter were internalized more effi-
ciently. Moreover, by analyzing CD4+ and CD8+ T cells,
B cells, NK cells, and monocytes, we surprisingly no-
ticed that f-CNTs have a cell specific effect. In fact,
none of them induced T cell expansion or activation
(evaluated by CD25, and CD69 markers), while all of
them were able to activate NK cells, which upregulated
CD69 and CD161 activation markers following f-CNTstreatment. Our study [31], which was the first one ex-
ploring the impact of nanotubes on natural killer cells,
suggests that the use of these f-CNTs could be explored
as tool for NK expansion, for example in pre-clinical
model of NK-based adoptive therapy. Similarly, the up-
regulation of CD25 and the production of IL-6 by CD14+
monocytes upon treatment with ammonium-functionalized
CNTsrevealed the activatory properties of these nanotubes
(see discussion in the following section) on innate immune
cells. Few research groups have started to look at the
impact of graphene and GO on the immune system.
The group of Liu showed that the complex between GO
and anti-IL10 receptor antibodies elicited LPS-stimulated
CD8 T cell responses, which makes this functionalized
graphene suitable for reprogramming suppressive tumor
environment in experimental models [34]. The first exten-
sive investigation on pristine and GO to assess hemocom-
patibility was performed by Sasidharan et al. [35]. The
authors observed a significant release of IL-8 and IL-6 in
pristine graphene treated PBMC, while GO was able to
determine only a moderate release of IL-8. No modulation
of the other inflammatory cytokines (IL1B, IL1, TNF, and
IL12) was observed. Importantly, the authors showed an
excellent compatibility of both types of graphene in mul-
tiple assays assessing hemolysis, platelet aggregation and
coagulation. The group of Cui addressed whether the
coating of GO with polyvinylpyrrolidone (PVP) could
increase biocompatibility GO with human immune
cells, including T lymphocytes [38]. Besides confirming
the GO dose-dependent toxicity on T cells, the authors
showed that the induction of apoptosis in these cells
was much less pronounced when PVP-coated GO was
used [38].
Monocytes
Monocytes in the blood of healthy people are the 10-30%
of PBMCs. Monocytes and their differentiated progeny
(macrophages and dendritic cells) play an important
role in both the innate and adaptive immunity, by exert-
ing immune-regulatory proprieties to the production of
several modulatory cytokines. These cells phagocyte
material for two purposes: i) to eliminate waste, and ii)
to destroy invading pathogens [41]. During a potential
injection of nanomaterials for diagnostic or therapeutic
purposes, monocytes will be the responsible population
for a possible innate response of the immune system. It
should be mentioned that different nanomaterial coat-
ing and functionalization are finalized not only to reach
a good biocompatibility but also to elude phagocytic-
mediated clearance. In this context a good example is
given by the work performed by the group of Tasciotti
[42], in which the authors showed how nanoporous sili-
con particles coated with cellular membranes can avoid
opsonization, delay uptake by mononuclear phagocytes
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of monocyte functions is desirable when the purpose is
to enhance the immunogenicity of a certain molecule.
In Additional file 2 we report the publications related
to the effects of the different carbon materials on
monocytes [31,39,43-47].
One of the first works carried out on monocytes was
conducted by Meunier et al. [43]. By assessing the effect
of pristine double-walled CNTs on monocytes, the
authors observed an induced IL-1beta secretion linked
to caspase-1 and to Nlrp3 inflammasome activation in
human monocytes, while no induction of the correspond-
ing mRNA was observed. The authors also showed that
similar increase of IL-1β was observed using oxidized
DWCNTs. However, the researchers did not assess
whether the IL-1beta release mediated by oxidized
CNTs was dissociated from the induction of caspase-
mediated apoptotic stimuli. In absence of functionaliza-
tion, in fact, CNTs are highly cytotoxic and can mediate
the induction of several inflammatory cytokines through
the activation of pathways associated to oxidative stress
and caspase cascade [48]. We found, however, that
MWCNTs oxidized and functionalized with ammonium
group by 1,3-dipolar cycloaddition induce the expres-
sion of the CD25 activation markers and release of
IL1beta, IL6, TNF, and IL10 by human monocytes not
accompanied by the activation of cytotoxic mechanisms
[31,39]. Recently, we provided more molecular insight
into down-stream events induced by f-CNTs [39]. Through
a genome-wide analysis on THP1 monocyte cell lines,
we showed that ammonium-functionalized as well as
oxidized MWCNTs with larger diameter provoke a pro-
found modulation of immune-regulatory pathways not
accompanied by the induction of apoptotic pathways.
We demonstrated that these f-CNTs induce profound
modulation of inflammatory molecules at the transcrip-
tomic level. Molecular pathways activated by these nano-
tubes include toll-like receptor (TLR), IL-6, dendritic cell
maturation, TNF, NFKB, and T helper 1 chemokine path-
ways (CXCR3 and CCR5 ligand pathways) [39]. Because of
the critical role of these inflammatory pathways (especially
the T helper 1 chemokine pathways) in controlling
immune-mediated tumor rejection, our findings sug-
gest the highly promising application of this type of
f-CNTs as adjuvant molecules in the contest of cancer
immunotherapy [49-52]. In contrast, thinner oxidized
MWCNTs down-modulated genes associated with ribo-
somal proteins in both monocyte and T cell lines. Gul-
Uludag et al. [46] analyzed THP1 cells using fluorescein
isothiocyanate (FITC)-labeled magnetic carbon nano-
tubes. Interestingly, the authors noticed an extremely
high uptake of this f-CNTs into this type of cells after
1 hour, whereas localization into nucleus was observed
6 hours after their administration. A recent deepevaluation of a wide variety of f-CNTs showed that
compared to raw MWCNTs, anionic functionalization
(carboxylated and PEGylated) decreased the production
of cytokines/growth factors by THP1 cells (IL-1beta) or
by THP1-cocultured with bronchial epithelial cell lines
(PDGF-AA, TGF-beta), while neutral and low degree of
CNT cationic functionalization showed intermediary
effects [47]. In particular, carboxylated MWCNTs did
not induce any inflammatory responses. However, high
degree of CNT cationic functionalization (PEI) induced
the greatest cytokine response, which was also associ-
ated to the development of pulmonary fibrosis following
nasopharingeal installations in mouse models. No sig-
nificant fibrosis development was observed in animals
treated with anionic nanotubes. Moreover, Wang et al.
[45] found that well dispersed MWCNTs by serum bo-
vine albumin elicited a more robust IL-1beta production
on THP1. Regarding graphene, studies have been focused
on macrophages and dendritic cells rather than on mono-
cytes (see following paragraphs).
Macrophages
Macrophages represent the differentiated counterpart of
monocytes in the peripheral tissue. For their phagocytic
characteristic and their pilot role in innate immunity,
interaction between macrophages and carbon nanotubes
has aroused great interest. A 56% of the studies here an-
alyzed were carried out on this immune cell population.
A possible reason of the large amount os studies is that
this cell type is an easy long-term culturing primary im-
mune cell population compare to T cells or natural killer
cells. Additional file 3 gives an overview on the papers
published in the last years on macrophage and their
interaction with carbon nanotubes, carbon nanohorns,
graphene and GO [16,22,29,35,38,45,47,53-103]. The large
majority of the work performed in vitro was carried out
using the murine macrophage cell line RAW 264.7, which
can guarantee high experimental reproducibility, it is easy
to culture and, being a good transfection host, it is suitable
for nanomaterial-based conjugate uptake assays. Dutta
et al. investigated the importance of plasma protein ad-
sorption by oxidized SWCNTs [54] using RAW 264.7.
Intriguingly, the authors noticed that the complex be-
tween SWCNT and albumin inhibited the induction of
cox-2 by LPS and suggested that the proteins adsorbed
onto nanotubes may alter their immune modulatory
and toxicity properties. Furthermore, other modifica-
tions (e.g. non anionic surfactant coating) could reduce
albumin adsorption and decreased their anti-inflammatory
properties. The work of Zhou et al. [63] elucidated mecha-
nisms of intracellular compartmentalization of functional-
ized SWCNTs by corroborating and expanding previous
observations [55,104]. Pantarotto et al. [104] had previ-
ously shown that f-CNTs are able to cross the cell
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the nucleus of living cell, while Porter et al. [55] observed
that SWCNT can cross the membrane of macrophage,
localize into the lysosomes and enter the nucleus. In
their work, Zhou et al. [63] studied in detail the cellular
localization of SWNT surface-modified with phospho-
lipids and polyethylene glycol (PL-PEG). The authors
reported that these functionalized SWCNTs localize
inside mitochondria if they cross the cell membrane or
inside lysosomes when they are endocytosized. A more
recent study also found similar results for carbon nano-
horns that are preferentially localized into macrophage
lysosomes opening future applications relying on lyso-
somes as target organelles for drug delivery or imaging
[79]. Dong et al. [77] tested pristine SWCNTs and acid-
functionalized SWCNTs showed on RAW 264.7 that
these materials could damage mitochondrial function
and proteasome.
Regarding carbon nanohorns, Lacotte et al. [103] found
that exposed macrophage increased the production of re-
active oxygen species and pro-inflammatory cytokines.
The authors suggested that a moderate level of inflamma-
tion could be exploited as an intrinsic carbon nanohorn
adjuvant function for biomedical applications requiring
some activation of the immune system. In the context
of graphene, the number of publications related to the
interaction of this material and the immune system are in-
creasing. It has been demonstrated that pristine graphene
can induce cytotoxicity on macrophage through the
depletion of the mitochondrial membrane potential and
the increase of intracellular reactive oxygen species [85].
Chen et al. [86] described instead the relations with GO
demonstrating that it is able to simultaneously trigger au-
tophagy and toll like receptors 4/9-regulated inflammatory
responses. Moreover, the authors reported that autophagy
was at least partly regulated by the toll-like receptor
(TLRs) pathway. The work of Sasidharan et al. [35] gave a
full picture of bio- and hemocompatibility of both pristine
graphene and GO on RAW 264.7 cells and human pri-
mary blood components. All the results suggested that the
toxicity of pristine graphene can be easily averted by sur-
face modification (i.e. GO). Recently, by focusing on the
effect of GO sheet lateral dimensions on human primary
monocyte-derived macrophages and murine intraperito-
neal macrophages, we demonstrated that the more the lat-
eral dimensions of GO were reduced, the higher were the
uptake and the impact of functionality [101]. Li et al. [99]
tried to understand the interaction between graphene and
cell membranes of primary human keratinocytes, human
lung epithelial cells and murine macrophages. The authors
showed that the entry is initiated at the asperities that are
abundant along the materials making clear that local pier-
cing initiates membrane propagation along the extended
graphene edge. Overall, there are very few data present forgraphene and GO keeping the door open to more mech-
anistic studies in vitro, ex vivo and in vivo.
Dendritic cells
Dendritic cells are specialized antigen-presenting cells
that circulate in the blood – where they represent 1-2%
of PBMCs- but are preferentially found in lymphoid
and peripheral organs. As showed in Figure 1A, studies
performed on dendritic cells are considerable less in num-
ber as compared to those performed on other antigen-
presenting cells. In Additional file 4 we summarized
the publications where the authors report findings
on DCs and their interaction with different materials
[32,33,36,38,53,59,102]. Tkatch et al. [32] investigated
in vivo and in vitro the effect of SWCNTs produced by
the high-pressure CO disproportionation (HipCO nano-
tubes). The authors showed that this type of SWCNTs can
induce pulmonary inflammation. The investigators ob-
served that SWCNTs also facilitated the recruitment of
DCs in lung tissues, while they were unable to interfere
with DC activation (assessed through the measurement
of CD80, CD86, CD40 and MHC class II molecules).
Surprisingly, SWCNT-treated DCs suppressed T cell
proliferation response. Different types of functionaliza-
tion can dramatically change the recognition profile by
DCs with consequent different effect on processing and
antigen presentation on T cells [32]. Accordingly, the same
group [59] demonstrated that coating SWCNTs with
anionic phospholipids (phosphatidylserine and diacyl-
phophatidylglycerol) can dramatically enhance their
recognition and uptake by phagocytes, such DCs. The
authors suggested that a phosphatidylserine coating can
be utilized for targeted delivery with specified cargoes
into professional phagocytes. Villa et al. [33] proved this
hypothesis coating CNTs with Wilm’s tumor protein
427 peptide (a vaccine tested in several clinical trials).
Immunization of BALB/c mice with the SWCNT-peptide
constructs, mixed with immunological adjuvants, induced
specific IgG responses against the peptide, proving that
CNTs are able to serve as antigen carriers for delivery into
antigen presenting cells (APCs).
Data on the effect of graphene on DCs are negligible.
Tkach et al. [36] showed that GO impairs the stimula-
tory potential of DCs by decreasing the intracellular
levels of LMP7 immunoproteasome subunits required
for processing of protein antigen. Polyvinylpyrrolidone
(PVP) coating on GO was recently investigated [38]. The
functionalization exhibited lower immunogenicity com-
pared with pure GO in inducing differentiation and mat-
uration. In the same work, other experiments performed
on Tcells and macrophages suggest that PVP-coating have
a good immunological biocompatibility and immune en-
hancement effects ex vivo. However, no papers are present
in the literature carrying out a deep toxicology analysis on
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has been investigated mostly in their single-walled form
and no data are available for carbon nanohorns.
Conclusions
Carbon nanotubes have been investigated with great
expectation by several research groups in many contexts,
ranging from electronics to medicine. Through the years,
however, their cytotoxic effects raised major concerns re-
garding the real possibility to apply carbon nanotubes in
medicine as diagnostic or therapeutic applications. Pristine
nanotubes in fact tend to form agglomerate, induce cellu-
lar necrosis/apoptosis and oxidative stress when ingested
by phagocytes. In mice, they determine formation of
granulomas, resembling in part the effect of asbestos
[48,105]. Moreover, carbon nanotubes can directly bind
some plasma protein as fibrinogen and apolipoproteins
and trigger activation of complement cascade [106]. Con-
cerning the cytotoxicity, in general, higher is the dose
higher is the toxic effect. The functionalization of pristine
nanotubes is clearly the key for improving their biocom-
patibility [107]. As described above, several studies have
demonstrated that some f-CNTs bear immunostimulatory
properties in absence of cytotoxicity. Importantly, most of
the studies have shown lack of relevant toxicity of f-CNTs
at relatively high concentrations both in vitro and in vivo.
However, several parameters as the number of walls,
the diameter, the length, and, importantly, the type of
functionalization can influence their cellular uptake
and/or toxicity. Moreover, the route of administration
is also a critical factor. For example, lung toxicity has
been observed for both pristine and functionalized carbon
nanotubes [108]. Toxicity of carbon nanotubes and regula-
tory aspects has been thoroughly revised elsewhere [109].
Graphene and GO seem to retrace the same road of
scientific expectation of CNTs. Even for this material a
careful assessment of toxicity in vitro and in vivo in
appropriate models is necessary before starting testing
in clinical trials [110]. Risk to benefit ratio needs to be
accurately evaluated before any medical application i.e.
as delivery tool, immunotheraphy and for biomarker
detection [111-113].
Even though there are many technical advantages in
using cell lines as model, more studies assessing perturb-
ation in primary human cells are needed. Studies per-
formed on healthy donors are carried out in most of the
case separating red blood cells from PBMCs. PBMCs
contain monocytes, T cells, B cells, NKs, and dendritic
cells. A more profound evaluation of the interaction of
some types of population is warranted. NKs and B cells
remain very poorly investigated. Studies directed at elu-
cidating the effects of carbon nanomaterials on specific
lymphocyte or monocyte subpopulations are lacking. For
example, it is totally missed the evaluation of monocytesubpopulation, as classical monocytes CD14+ CD16-, and
non-classical monocytes with low level expression of
CD14 and high co-expression of the CD16.For T cell
studies, taking in consideration T regulatory cells and
different stage of T cell maturations are desired.
Moreover, we noticed an almost absence of compara-
tive data on many immune cell types at the same time.
Looking at different cell type simultaneously would pro-
vide more insight into putative cell-type restricted effects
of certain nanomaterials.
It is well known for carbon nanotubes that length and
functionalization can lead to very difference reactions on
cells, and it is of critical importance to differentiate car-
bon nanotubes in terms of physical and chemical charac-
teristics. Learning from CNT literature, scientists should
be aware to apply this state of mind also to the new born
graphene, where lateral dimension and functionalization
most likely can make huge difference in immune cells
behaviors.
Here we showed that a considerable number of publi-
cations combining in vitro and in vivo data were carried
out in mice models. Results of pre-clinical studies in
mouse, however, should be taken with caution consider-
ing their profound difference in physiological immune
responses compare to humans [114]. Regarding gene ex-
pression data, we found very few works employing a
high throughput design. Whole genome gene-expression
is able to give an overall picture of the molecular changes
following experimental perturbation. This approach was
carried out by Chou et al. [48] to investigate the effect of
non-functionalized SWCNTs on THP1 derived macro-
phages using one type of nonfunctionalized nanotubes.
Using the same powerful tool we recently provided a
precise portrait of the molecular perturbation induced
by f-CNTs on T and monocytes human cell lines [39].
As described above, we found that the main effect of
MWCNTs (oxidized and further functionalized with
ammonium groups) is the induction of specific inflam-
matory molecular pathways on monocytes, while no
relevant immunologic effect on T cells were observed.
However, functionalized MWCNTs of low diameter but
lacking ammonium group were unable to induce immune
activation. Rather, they determine profound modulation
on genes encoding ribosomal proteins in both monocytes
and T cells. Altogether, these results suggest that some
f-CNTs bear an intrinsic immune-modulatory propriety
and that this effect is cell specific. These immune-
modulatory f-CNTs emerge as potential adjuvant for
immune-based therapies against infectious disease and
cancer [50]. Notably, molecular pathways activated in
monocytes after f-CNT stimulation resemble somehow
those that can be obtained through the activation of
TLRs, which recognize pathogen-associated molecular
patterns. Importantly, mononuclear phagocytes express
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part explain the inability of those f-CNTs to induce the
same profound immune-modulation on T cells. Although
activation of TLRs is plausible, this mechanism has not
been conclusively demonstrated yet. However, several
TLRs exist, and mechanistic studies aimed at defining the
molecular target of f-CNTs represent an urgent subject. In
conclusion, many observations suggest that CNTs and
nanohorns can exert an immune modulatory effect, but
their physical molecular interaction need to be elucidated.
On the other hand, the very limited amount of works
available in the literature for graphene make this area of
research one of the more enthusiastic challenge in the
near future nanomedicine scenario.
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